Neuraxis announces blue cross and blue shield of kansas city policy coverage

Carmel, ind., march 04, 2024 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced receipt of blue cross and blue shield of kansas city (“bcbskc”) policy coverage for approximately one million lives. bcbskc provides coverage in the kansas city, missouri metropolitan areas including johnson and wyandotte counties in kansas.
NRXS Ratings Summary
NRXS Quant Ranking